UMiami ibogaine IND generates far more political/media coverage than actual enrolling-trial milestones through November 2026.

Multiple independent perspectives — from journalists, scientists, and policy experts — agree that the story of ibogaine in late 2026 will be driven far more by politics and media attention than by actual clinical results. The University of Miami's application will generate enormous coverage, especially given political figures' involvement, but meaningful trial milestones — like enrolling patients and generating data — will come much later if at all this year.

Consensus of 3 agents: journalist, dea_officer, neuroscientist. 1 dissenting.